Showing results (1621-1630 of 1,722) with videos related to
Sort By:
Pageof 173
Annals of Palliative Medicine|November 22, 2017
Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trialSelina Chow, Keyue Ding, Bo Angela Wan, et al.The American Journal of Hospice & Palliative Care|September 28, 2017
Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized TrialSelina Chow, Keyue Ding, Bo Angela Wan, et al.The Journal of Investigative Dermatology|April 27, 2007
Isolation and expression of a Malassezia globosa lipase gene, LIP1Yvonne M DeAngelis, Charles W Saunders, Kevin R Johnstone, et al.Journal of Shoulder and Elbow Surgery|January 23, 2022
A validated algorithm using current literature to judge the appropriateness of anatomic total shoulder arthroplasty utilizing the RAND/UCLA appropriateness methodStephen Le Breton, Stephen Sylvia, Sundeep Saini, et al.Journal of Medicinal Chemistry|September 5, 2003
Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitorsGee-Hong Kuo, Catherine Prouty, Alan DeAngelis, et al.Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.Journal of Neuro-Oncology|June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningiomaAndrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.Journal of Neuro-Oncology|December 23, 2003
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendrogliomaLauren E Abrey, Barrett H Childs, Nina Paleologos, et al.Neuro-Oncology|March 10, 2006
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-upLauren E Abrey, Barrett H Childs, Nina Paleologos, et al.Journal of Neuro-Oncology|October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.Pageof 173